Manufacturing

Amicus Therapeutics is creating the Global Research and Gene Therapy Center of Excellence in Philadelphia. The 75,000-sf facility will provide collaborative laboratories and offices for the discovery and development of treatments for rare metabolic diseases. Accommodating up to 200 employees, the center will serve as the headquarters for the global Amicus science organization and the gene therapy division’s leadership team. Occupancy is expected in the second half of 2019.

Autolus Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for the construction and development of a build-to-suit facility in Rockville, Md. Located in the Shady Grove Life Sciences Center, the 85,000-sf project will accommodate the company's U.S. headquarters and a commercial-scale manufacturing center for cell therapies. Occupancy is expected in 2021.

EMD Serono is planning to construct a $70 million R&D facility on its existing campus in Billerica, Mass. Supporting research programs in oncology, immuno-oncology, and immunology, the 145,000-sf building will accommodate wet labs, offices, collaboration spaces, and a cafeteria. Designed to attain LEED and WELL certification, the project will provide a healthy and sustainable environment for approximately 400 employees. Completion is expected in 2021. EMD Serono is the biopharmaceutical business of Merck KGaA, based in Darmstadt, Germany.

Mitsubishi Electric Corporation is planning to build a $33 million R&D facility for the creation of technologies for Zero Energy Buildings (ZEB) in Kamakura, Japan. The project will accelerate the company’s development, evaluation, and demonstration of ZEB technologies to meet the growing demand for buildings that combine comfort and superior energy savings. Mitsubishi Electric’s ZEB technologies are part of the company’s wide-ranging effort to help achieve the United Nation’s Sustainable Development Goals.

Catalent is initiating an expansion of its biologics manufacturing operations. The global biotechnology company will construct a 60,000-sf facility on its existing campus in Madison, Wis. The project is slated for completion by 2021 and represents an investment of $100 million over the next three years. Catalent will also invest $100 million to increase its manufacturing capacity in Bloomington, Ind.

Global life science company Promega is constructing a $190 million research and development center on its existing campus in Fitchburg, Wis. Offering laboratories with sophisticated infrastructure to support the creation of innovative bioscience products and technologies, the three-story, 270,000-sf facility will enable the consolidation of operations currently located in three separate buildings. Ground was broken on the project in July of 2018 and occupancy is expected in fall of 2020. 

GKN Aerospace is planning to build the £32 million Global Technology Centre in Bristol in the United Kingdom. The 108,000-sf facility will accommodate 300 engineers engaged in collaborative research on additive manufacturing, advanced composites, and next-generation aircraft production. The public-private project is supported by £15 million in government funding and is slated for occupancy in 2020.

Merck began construction in January of 2019 on a $300 million pharmaceutical formulation and process development facility in Rahway, N.J. Designed for maximum flexibility, the Formulation Laboratory Experimental (FLEx) Center will feature modular cleanrooms and cGMP manufacturing suites to support multiple modalities including large and small molecule, sterile, and oral solid-dosage products.

Brammer Bio is developing two gene therapy manufacturing facilities in Massachusetts. The company will build out 35,000 sf in an existing 50,000-sf structure in Lexington to create a cGMP manufacturing and quality control operations center. Additionally, Brammer will renovate 8,000 sf in its 66,000-sf commercial cGMP plant in Cambridge to create new production suites to support manufacturing capacity expansion. DPS Group is providing architectural and engineering services for both projects, which are slated for completion in mid-2019.

Fujifilm Cellular Dynamics is creating a stem cell manufacturing center in Madison, Wis. Located in the University Research Park, the $21 million project involves the renovation of 31,500 sf in a facility near the company's existing lab and office building. The completed biomanufacturing plant will meet the requirements of the U.S. Food and Drug Administration. Completion is expected by March of 2020.

Park Electrochemical Corporation is planning a $19 million expansion of its aerospace design, development, and manufacturing operations in Newton, Kansas. Doubling the company's existing footprint at the Newton City-County Airport, the 90,000-sf facility will accommodate new mixing and delivery systems, hot-melt film and tape production lines, secure joint project suites, labs, offices, and additional freezer and storage areas. Construction will begin by mid-2019 with completion expected in spring of 2020.

Merck will break ground in January of 2019 on a $28 million pharmaceutical research and distribution center in Visalia, Calif. The 123,332-sf facility will be located in the Visalia Industrial Park and can be expanded by 160,000 sf to accommodate future growth. The developer for the project is Scannell and completion is expected in late 2019. Merck is based in Darmstadt, Germany.

Heriot Watt University is planning to construct the National Robotarium in Edinburgh in the United Kingdom. Created in partnership with the University of Edinburgh, the £100 million innovation hub will support research and development on robotics and autonomous systems as well as providing instruction and training facilities for computational science programs. The project is an integral part of the region’s Data Driven Innovation (DDI) initiative that aims to establish the area as the data capital of Europe. Occupancy is expected in 2021. 

Sanofi announced the lease of 900,000 sf in two buildings in the Cambridge Crossing development in December of 2018. The French pharmaceutical manufacturer will occupy approximately a fifth of the 45-acre campus spanning Cambridge, Boston, and Somerville. The project will provide collaborative laboratory and office space for 2,700 Sanofi employees.

The University of Manchester opened the £60 million Graphene Engineering Innovation Centre in December of 2018 in the United Kingdom. Located in the new 91,000-sf Masdar Building on the North campus, the facility will accommodate collaborative materials science research and development with King Abdullah University of Science and Technology (KAUST) and Khalifa University of Science and Technology.